This topic contains a solution. Click here to go to the answer

Author Question: The brain structure that monitors angiotensin levels and stimulates thirst is the: a. ... (Read 51 times)

chandani

  • Hero Member
  • *****
  • Posts: 541
The brain structure that monitors angiotensin levels and stimulates thirst is the:
 
  a. hypothalamus
  b. cerebellum
  c. thalamus
  d. subfornical organ

Question 2

Blood loss, diarrhea and vomiting can all lead to _____.
 
  a. loss of extracellular fluid or hypovolemia
  b. loss of cellular fluid and diabetes insipidus
  c. loss of cellular fluid and thirstd stimulation of the hypothalamus



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

beccamahon

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

d

Answer to Question 2

a




chandani

  • Member
  • Posts: 541
Reply 2 on: Jun 20, 2018
:D TYSM


sultana.d

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library